XHQHX: Tekla Healthcare Investors - MutualFunds.com
Continue to site >
Trending ETFs

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$26.74

-

-

-

Vitals

YTD Return

4.5%

1 yr return

20.6%

3 Yr Avg Return

10.0%

5 Yr Avg Return

10.0%

Net Assets

$1.2 B

Holdings in Top 10

35.2%

52 WEEK LOW AND HIGH

$26.67
$23.24
$28.49

Expenses

OPERATING FEES

Expense Ratio N/A

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 52.44%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Closed-end mutual fund

Investment Style

Health


Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$26.74

-

-

-

XHQHX - Profile

Distributions

  • YTD Total Return 4.5%
  • 3 Yr Annualized Total Return 10.0%
  • 5 Yr Annualized Total Return 10.0%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -0.20%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Quarterly

Fund Details

  • Legal Name
    Tekla Healthcare Investors
  • Fund Family Name
    Hambrecht & Quist
  • Inception Date
    Apr 23, 1987
  • Shares Outstanding
    45033795
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Daniel Omstead

Fund Description

N/A


XHQHX - Performance

Return Ranking - Trailing

Period XHQHX Return Category Return Low Category Return High Rank in Category (%)
YTD 4.5% -80.1% 37.9% 77.46%
1 Yr 20.6% -28.4% 92.6% 75.25%
3 Yr 10.0%* -0.3% 38.2% 83.78%
5 Yr 10.0%* 2.2% 38.6% 91.55%
10 Yr 15.4%* 9.4% 21.6% 74.80%

* Annualized

Return Ranking - Calendar

Period XHQHX Return Category Return Low Category Return High Rank in Category (%)
2020 8.4% -13.6% 178.2% 71.51%
2019 14.7% 3.8% 63.8% 83.45%
2018 -14.9% -49.7% 21.5% 84.67%
2017 6.9% -59.8% 54.4% 87.41%
2016 -26.4% -36.6% 11.6% 96.09%

Total Return Ranking - Trailing

Period XHQHX Return Category Return Low Category Return High Rank in Category (%)
YTD 4.5% -79.8% 42.1% 77.93%
1 Yr 20.6% -30.4% 92.6% 63.80%
3 Yr 10.0%* -15.9% 38.2% 81.56%
5 Yr 10.0%* -7.4% 38.6% 86.71%
10 Yr 15.4%* 9.4% 21.6% 66.92%

* Annualized

Total Return Ranking - Calendar

Period XHQHX Return Category Return Low Category Return High Rank in Category (%)
2020 8.4% -13.6% 178.2% 71.51%
2019 14.7% 3.8% 63.8% 83.45%
2018 -14.9% -25.3% 22.2% 86.13%
2017 6.9% -10.8% 54.4% 93.33%
2016 -26.4% -36.6% 11.6% 98.44%

NAV & Total Return History


XHQHX - Holdings

Concentration Analysis

XHQHX Category Low Category High XHQHX % Rank
Net Assets 1.2 B 2.72 M 53.2 B 43.75%
Number of Holdings 173 11 478 6.78%
Net Assets in Top 10 393 M 2.18 K 21.1 B 36.86%
Weighting of Top 10 35.20% 10.1% 94.7% 70.76%

Top 10 Holdings

  1. Gilead Sciences Inc 5.44%
  2. Illumina Inc 4.72%
  3. Amgen Inc 4.46%
  4. Seagen Inc Ordinary Shares 4.13%
  5. Vertex Pharmaceuticals Inc 4.01%
  6. Moderna Inc 3.52%
  7. Horizon Therapeutics PLC 3.26%
  8. Alexion Pharmaceuticals Inc 3.26%
  9. Biogen Inc 3.24%
  10. Regeneron Pharmaceuticals Inc 3.16%

Asset Allocation

Weighting Return Low Return High XHQHX % Rank
Stocks
94.36% 83.68% 104.21% 94.49%
Preferred Stocks
5.07% 0.00% 5.83% 2.54%
Cash
0.84% -0.65% 9.16% 36.44%
Convertible Bonds
0.00% 0.00% 0.06% 72.88%
Bonds
0.00% 0.00% 17.12% 74.15%
Other
-0.28% -26.05% 9.11% 95.76%

Stock Sector Breakdown

Weighting Return Low Return High XHQHX % Rank
Healthcare
99.83% 61.99% 100.00% 46.19%
Financial Services
0.17% 0.00% 1.78% 23.31%
Utilities
0.00% 0.00% 0.98% 72.46%
Technology
0.00% 0.00% 19.13% 75.00%
Real Estate
0.00% 0.00% 6.19% 74.15%
Industrials
0.00% 0.00% 7.02% 73.73%
Energy
0.00% 0.00% 0.71% 72.46%
Communication Services
0.00% 0.00% 7.81% 74.15%
Consumer Defense
0.00% 0.00% 28.21% 75.00%
Consumer Cyclical
0.00% 0.00% 17.63% 74.15%
Basic Materials
0.00% 0.00% 8.23% 79.24%

Stock Geographic Breakdown

Weighting Return Low Return High XHQHX % Rank
US
89.07% 57.23% 100.70% 44.07%
Non US
5.29% 0.00% 42.77% 82.63%

XHQHX - Expenses

Operational Fees

XHQHX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio N/A 0.08% 2.91% 45.56%
Management Fee 1.00% 0.00% 1.25% 89.77%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

XHQHX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

XHQHX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

XHQHX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 52.44% 0.00% 256.00% 63.47%

XHQHX - Distributions

Dividend Yield Analysis

XHQHX Category Low Category High XHQHX % Rank
Dividend Yield 0.00% 0.00% 2.44% 75.74%

Dividend Distribution Analysis

XHQHX Category Low Category High Category Mod
Dividend Distribution Frequency Quarterly Annually Monthly Semi-Annually

Net Income Ratio Analysis

XHQHX Category Low Category High XHQHX % Rank
Net Income Ratio -0.20% -2.54% 1.92% 61.27%

Capital Gain Distribution Analysis

XHQHX Category Low Category High Capital Mode
Capital Gain Distribution Frequency

Dividend Payout History

View More +

XHQHX - Fund Manager Analysis

Managers

Daniel Omstead


Start Date

Tenure

Tenure Rank

Sep 30, 2001

19.93

19.9%

Omstead is president and chief executive officer of Tekla Capital Management, formerly known as Hambrecht & Quist Capital Management, Inc. Before joining the adviser, Omstead was president and CEO of Reprogenesis, Inc., a private development stage biotech company developing therapies in the field of regenerative medicine. Before joining Reprogenesis, he was senior vice president, research and development at Cytotherapeutics, Inc., a public biotech company that developed CNS therapies.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.03 23.98 6.66 1.38